Potent and highly selective CDK9 inhibitor for treatment of hematologic malignancies
Effect of GFH009 treatment on CDK9-dependent protein expression in vivo. Credit: 2023 Zhou et al To evade cell cycle controls, ...
Effect of GFH009 treatment on CDK9-dependent protein expression in vivo. Credit: 2023 Zhou et al To evade cell cycle controls, ...
For adults with hematologic malignancies receiving chimeric antigen receptor T-cell (CAR-T) therapy, quality of life (QoL) deteriorates and physical and ...